The ESMO Pocket Guidelines provide easily accessible abridged versions of ESMO Clinical Practice Guidelines. The ESMO Interactive Guidelines App is compatible with Android and iOS devices and includes content from the ESMO Pocket Guidelines.
These quick reference booklets provide the most important content of the full ESMO Clinical Practice Guidelines on the management of various cancers. Key content includes diagnostic criteria, staging of disease, treatment plans and follow-up. The approval and licensed indication of drugs mentioned in these pocket guidelines may vary in different countries. Please consult your local prescribing information.
Printed copies of the Pocket Guidelines are distributed during ESMO events.
Includes newly diagnosed and relapsed epithelial ovarian carcinoma, nonepithelial ovarian cancer, cervical cancer, endometrial cancer and gestational trophoblastic disease.
Includes early-stage, locally advanced and metastatic non-small-cell lung cancer, small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours.
Includes central venous access in oncology, prevention of chemotherapy- and radiotherapy-induced nausea and vomiting, febrile neutropaenia, mucositis, venous thromboembolism, infusion reactions, anaemia and iron deficiency, diarrhoea, toxicities from immunotherapy, chemotherapy extravasation, diarrhoea, cardiac disease, fatigue and anticancer therapy-induced peripheral and central neurotoxicity.
Includes prostate cancer, bladder cancer, renal cell carcinoma, penile cancer and testicular seminoma and non-seminoma.
Published October 2018
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
